Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

More enediyne compounds from Sanwa Kagaku and Nagoya University

July 14, 1997

ALRT reports clinical trial status of Panretin

July 11, 1997

Paclitaxel derivatives developed at Bristol-Myers Squibb

July 11, 1997

Sparta's Spartaject busulfan enters phase I

July 11, 1997

GeneMedicine and UCSF enter into gene therapy collaboration

July 11, 1997

Banyu claims farnesyltransferase inhibitors

July 11, 1997

New antitumor taxanes from Yakult Honsha

July 11, 1997

Hycamtin launched in Canada

July 10, 1997

Kyowa Hakko develops cell adhesion inhibitors

July 10, 1997

Immunex receives approval to market paclitaxel in Canada

July 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...